Pelthos Therapeutics Inc.
PTHS · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $14,253 | $59 | $131 | $513 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7,988 | $40 | $40 | $40 |
| Inventory | $24,096 | $0 | $0 | $0 |
| Other Curr. Assets | $2,713 | $723 | $739 | $815 |
| Total Curr. Assets | $49,050 | $823 | $911 | $1,369 |
| Property Plant & Equip (Net) | $13,526 | $0 | $0 | $0 |
| Goodwill | $30,625 | $0 | $0 | $0 |
| Intangibles | $32,521 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $711 | $0 | $0 | $0 |
| Total NC Assets | $77,383 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $126,433 | $823 | $911 | $1,369 |
| Liabilities | – | – | – | – |
| Payables | $5,666 | $4,989 | $2,604 | $1,897 |
| Short-Term Debt | $631 | $2,305 | $2,503 | $2,186 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1,019 | $0 | $0 | $0 |
| Other Curr. Liab. | $17,452 | $24 | $0 | $0 |
| Total Curr. Liab. | $24,768 | $7,317 | $5,107 | $4,083 |
| LT Debt | $2,849 | $0 | $0 | $0 |
| Deferred Rev, NC | $1,522 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $12,866 | $0 | $0 | $0 |
| Other NC Liab. | $26,175 | $0 | $0 | $0 |
| Total NC Liab. | $43,412 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2,849 | $0 | $0 | $0 |
| Total Liabilities | $68,180 | $7,317 | $5,107 | $4,083 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $1 | $1 |
| Retained Earnings | -$43,130 | -$26,892 | -$23,443 | -$21,475 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $101,383 | $20,397 | $19,246 | $18,760 |
| Total Equity | $58,253 | -$6,494 | -$4,196 | -$2,714 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $126,433 | $823 | $911 | $1,369 |
| Net Debt | -$10,773 | $2,246 | $2,372 | $1,673 |